First Author | Sarroca S | Year | 2016 |
Journal | Neurobiol Aging | Volume | 46 |
Pages | 169-79 | PubMed ID | 27498054 |
Mgi Jnum | J:239461 | Mgi Id | MGI:5828951 |
Doi | 10.1016/j.neurobiolaging.2016.07.002 | Citation | Sarroca S, et al. (2016) Preservation of cell-survival mechanisms by the presenilin-1 K239N mutation may cause its milder clinical phenotype. Neurobiol Aging 46:169-79 |
abstractText | Presenilin 1 (PSEN1) mutations are the main cause of monogenic Alzheimer's disease. We studied the functional effects of the mutation K239N, which shows incomplete penetrance at the age of 65 years and compared it with the more aggressive mutation E120G. We engineered stable cell lines expressing human PSEN1 wild type or with K239N or E120G mutations. Both mutations induced dysfunction of gamma-secretase in the processing of amyloid-beta protein precursor, leading to an increase in the amyloid beta42/amyloid beta40 ratio. Analysis of homeostatic mechanisms showed that K239N induced lower basal and hydrogen peroxide induced intracellular levels of reactive oxygen species than E120G. Similarly, K239N induced lower vulnerability to apoptosis by hydrogen peroxide injury than E120G. Accordingly, the proapoptotic signaling pathways c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase maintained PSEN1-mediated negative regulation in K239N but not in E120G-bearing cells. Furthermore, the activation of the prosurvival signaling pathways mitogen-activated protein kinase/extracellular signal-regulated kinase and phosphoinositide 3-kinase/Akt was lower in E120G-bearing cells. Therefore, preservation of mechanisms regulating cell responses independent of amyloid-beta protein precursor processing may account for the milder phenotype induced by the PSEN1 K239N mutation. |